Navigation Links
Impotence Drugs May Aid Brain Tumor Treatment
Date:5/12/2010

Levitra, Viagra allowed anti-cancer medication to more easily penetrate brain barrier, study found

WEDNESDAY, May 12 (HealthDay News) -- A drug already approved for the treatment of erectile dysfunction may actually help boost the effectiveness of treatments for brain tumors tied to both lung and breast cancer, research shows.

The finding stems from an animal study that indicated that leading erectile dysfunction medications sildenafil (Viagra) and vardenafil (Levitra) can enable the chemotherapy drug Herceptin to more easily penetrate the so-called blood-brain barrier that must be breached in order to successfully target cancer that has spread to the brain.

Although the blood-brain barrier is a naturally occurring mechanism designed to protect the brain from exposure to dangerous substances, in the case of cancer treatment it can significantly impede drug delivery, particularly of large-molecule drugs, such as Herceptin. However, erectile dysfunction drugs appear to increase the barrier's permeability.

"No matter how effective against cancer a chemotherapeutic agent may be, it can have little impact on brain tumors if it cannot cross the blood-brain tumor barrier," Dr. Keith Black, chairman of Cedars-Sinai's department of neurosurgery and director of the Maxine Dunitz Neurosurgical Institute in Los Angeles, said in a news release. "As we find new drugs that are able to target these tumor cells, it is imperative that we develop better ways to enable the medications to reach their targets."

The study team notes that about 220,000 Americans develop brain tumors each year as a result of cancers that begin elsewhere in the body. Lung cancer, they note, is the leading cause of cancer mortality in the United States, and about one-fifth of lung cancer cases end up spreading to the brain.

Work with mice demonstrated that initial Levitra exposure effectively doubled the amount of Herceptin that was able to reach brain tumors linked to lung and breast cancer.

What's more, when administering Herceptin and Levitra together, survival among the mice increased by 20 percent compared to treatment with just Herceptin alone.

The findings were published online recently in the journal PLoS One.

More Information

For more on brain tumors, visit the U.S. National Cancer Institute.



-- Alan Mozes



SOURCE: Cedars-Sinai Medical Center, news release, May 7, 2010


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Monitoring and control can limit side effects of promising cancer drugs
2. Parkinsons Drugs Tied to Compulsive Behaviors
3. Stomach Acid Drugs Come with Dangers, Studies Show
4. Anemia Drugs Hold Dangers for Kidney Patients
5. As FDA Eyes Prostate Cancer Drugs, Experts Urge Caution
6. Taking Flu Drugs While Pregnant Appears to Be Safe: Study
7. OTC Drugs May Work Differently in Obese Kids
8. Study finds that drugs used for treatment of influenza in pregnancy appear to be safe
9. BATTLE links potential biomarkers to drugs for lung cancer
10. Matching Tumor Types to Drugs Boosts Lung Cancer Outcomes
11. Cholesterol Drugs May Slow MS
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/25/2017)... KY (PRWEB) , ... April 25, 2017 , ... ... announce they have signed an agreement to be the preferred physical therapy provider ... injuries and returning them to Derby City CrossFit as quickly and effectively as ...
(Date:4/25/2017)... ... April 25, 2017 , ... ... compare student test score performance for the 2015-16 school year across Wisconsin’s public ... programs. Though it highlights important patterns in student test score performance, the report’s ...
(Date:4/25/2017)... ... 25, 2017 , ... As pharmaceutical companies are held to ... process innovation in drug formulation and manufacturing. CoreRx offers its clients more ... in support of their development and manufacturing goals. , The company was ...
(Date:4/25/2017)... ... April 25, 2017 , ... Saad B. Chaudhary, MD is committed to providing the ... or chronic problems, I focus on preventative care with all my patients to alleviate possible ... questions, always feel free to contact my office and my trained staff will assist you ...
(Date:4/25/2017)... ... April 25, 2017 , ... Vetoquinol USA® , a ... UCII, part of the EQUISTRO line, at this week’s Rolex Kentucky Three-Day Event ... the immunologic level. , The scientifically-developed Flexadin UCII supports the body’s normal repair ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... , April 20, 2017  Zimmer Biomet Holdings, ... musculoskeletal healthcare, today announced that it will be participating ... Conference at the InterContinental Hotel in Boston, ... Biomet will present at 11:20 a.m. Eastern Time. ... accessed via Zimmer Biomet,s Investor Relations website at ...
(Date:4/20/2017)... -- Research and Markets has announced the addition of ... Expanding Injectables Market and Increasing Usage of Complex Biologics during the ... ... from USD 20 Billion in 2015 to around USD 26 Billion ... Innovation Driven by Rapidly Expanding Injectables Market and Increasing Usage of ...
(Date:4/20/2017)...  AbbVie (NYSE: ABBV), a global biopharmaceutical company, ... hepatitis C virus (HCV) infected patients with genotype ... cirrhosis (Child-Pugh A) achieved sustained virologic response at ... investigational, pan-genotypic regimen of glecaprevir/pibrentasvir (G/P). These high ... weeks of G/P treatment without ribavirin. Patients with ...
Breaking Medicine Technology: